Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4650313

ZANDATRIGINE
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
Cc1cc(S(=O)(=O)Nc2cscn2)c(F)cc1N(C)[C@H]1CCN(Cc2ccccc2)C1

Basic Information

ChEMBL ID CHEMBL4650313
Name ZANDATRIGINE
Phase Phase II
Structure Type MOL
InChI Key UCSHINHOAVARGQ-SFHVURJKSA-N

Known Names

Nbi-921352 XEN-901 Xen901 Zandatrigina Zandatrigine
2
Targets
5
Activities
1
Assay Types
0
PK Parameters
0
Publications
5
Known Names
1
Indications
1
Mechanisms

Molecular Properties

460.6
MW (Da)
4.10
ALogP
6
HBA
1
HBD
65.5
PSA (Ų)
0.58
QED
0
Ro5 Violations
7
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Single Enantiomer
USAN Stem -trigine
USAN Year 2024

Extended Properties

Molecular Formula C22H25FN4O2S2
MW 460.60
Aromatic Rings 3
Heavy Atoms 31
NP-Likeness -2.12

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Sodium channel protein type VIII alpha subunit inhibitor INHIBITOR Sodium channel protein type 8 subunit alpha

Indications

Seizures

Activity Summary

IC50 5 meas. best 7.27

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Sodium channel protein type 8 subunit alpha
CHEMBL5202
IC50 7.27 6.92 54.0 2
Unchecked
CHEMBL612545
IC50 4.81 4.64 15599.0 3

Activity Data Samples

Top measurements by pChEMBL value

Data from ChEMBL 36 via Core Engine